Spectrum News: University of Cincinnati study looks at impact of Narcan distribution
Study also reported on by Local 12
Research from the University of Cincinnati investigates the impact of a community naloxone distribution collaborative in Hamilton County from the end of 2017 until the end of 2019. The study, published in PLOS One, shows that widespread community distribution of naloxone did not significantly impact the median monthly opioid overdose rates.
Spectrum News reported on the research, interviewing lead researcher, Caroline Freiermuth, MD, of the Department of Emergency Medicine in the UC College of Medicine.
Caroline Freiermuth, MD, of the Department of Emergency Medicine in the UC College of Medicine/Photo/Colleen Kelley/UC Marketing + Brand
“We found that over the course of the two-year project where we were trying to distribute naloxone to as many communities possible, the overdose death rate really did not change," said Freiermuth. "However, we did some modeling and we would have expected to see the opioid overdose death rate go up. And so we like to think that handing out the naloxone actually kept that at a steady rate.”
Freiermuth told Spectrum News that one thing the study demonstrates is that much work needs to be done in this area.
"We need to make sure that everyone has access to this medication, knows how to use this medication, realizes how easy and impactful it is," she said. "This is such a safe medication. It’s very easy to administer. It works within seconds and really can help bring people back from death.”
Local 12 also reported on the research. See that coverage here.
Read more about the study here.
Lead photo/Mark Schiefelbein/AP photo
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
6 ways starting a GLP-1 medication could affect your emotions
May 20, 2026
When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.
UC researchers recruit older adults for extreme heat health study
May 20, 2026
The University of Cincinnati’s Center for Collaboration on Climate & Community for Health (C4H) is recruiting older adults to participate in a study tracking their health during periods of extreme summer heat.
$15 million bequest supports endowed chair at UC College of Medicine
May 19, 2026
As a student and resident at the University of Cincinnati College of Medicine, George G. Bemis, Jr., MD, Med ’64, saw firsthand that medicine was more than a profession for those teaching and leading him. Inspired by their sense of calling, he knew he wanted to pursue the same path.